These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7935939)

  • 41. [Hepatitis caused by amoxicillin plus clavulanic acid].
    del Olmo ME; Panadero FJ; Palacios ML; Carreira J; Panadero E
    Aten Primaria; 1994 Jun; 14(1):579-80. PubMed ID: 7918969
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical trials of the combination amoxicillin-clavulanic acid in pediatrics].
    Borderon JC; Ramponi N; Ployet MJ; Despert F; Bloc D; Laugier J
    Ann Pediatr (Paris); 1985 Dec; 32(10):895-9. PubMed ID: 4091446
    [No Abstract]   [Full Text] [Related]  

  • 43. Severe penicillin allergy precipitated by inhalation and topical exposure to co-amoxiclav (Augmentin).
    Jarrett P; Rademaker M
    N Z Med J; 1996 Sep; 109(1030):366. PubMed ID: 8890865
    [No Abstract]   [Full Text] [Related]  

  • 44. Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.
    Larrey D; Vial T; Micaleff A; Babany G; Morichau-Beauchant M; Michel H; Benhamou JP
    Gut; 1992 Mar; 33(3):368-71. PubMed ID: 1568657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acute pancreatitis associated with hepatotoxicity induced by amoxicillin-clavulanic acid].
    Galindo C; Buenestado J; Reñé JM; Piñol MC
    Rev Esp Enferm Dig; 1995 Aug; 87(8):597-600. PubMed ID: 7577112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cholestatic hepatitis caused by amoxycillin-clavulanic acid. Report of a new case].
    Bustamante Balén M; Pérez Aguilar F; Rayón Martín M; García Herola A; Berenguer Lapuerta J
    Gastroenterol Hepatol; 1997 Apr; 20(4):187-9. PubMed ID: 9280613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of abnormal liver function tests associated with administration of amoxicillin and other penicillins.
    Harrison CJ
    Pediatr Infect Dis J; 1993 Jun; 12(6):547. PubMed ID: 8345994
    [No Abstract]   [Full Text] [Related]  

  • 48. Sensitization to amoxycillin in Augmentin.
    Kennedy C; Stolz E; van Joost T
    Contact Dermatitis; 1989 Apr; 20(4):313-4. PubMed ID: 2752748
    [No Abstract]   [Full Text] [Related]  

  • 49. Cholestatic hepatitis due to an amoxycillin/clavulanic acid preparation.
    Verhamme M; Ramboer C; Van de Bruaene P; Inderadjaja N
    J Hepatol; 1989 Sep; 9(2):260-4. PubMed ID: 2809168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.
    Crokaert F; van der Linden MP; Yourassowsky E
    Antimicrob Agents Chemother; 1982 Aug; 22(2):346-9. PubMed ID: 6765418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Spektramox and liver damage].
    Lakartidningen; 1996 Feb; 93(6):490. PubMed ID: 8637331
    [No Abstract]   [Full Text] [Related]  

  • 52. Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin +/- dicloxacillin.
    Goldstein EJ; Reinhardt JF; Murray PM; Finegold SM
    Int J Dermatol; 1987 Mar; 26(2):123-7. PubMed ID: 3106248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for the development of amoxycillin-clavulanic acid associated jaundice.
    Thomson JA; Fairley CK; Ugoni AM; Forbes AB; Purcell PM; Desmond PV; Smallwood RA; McNeil JJ
    Med J Aust; 1995 Jun; 162(12):638-40. PubMed ID: 7603374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Significance of Staphylococcus aureus in nose operations. Risk of toxic shock syndrome?].
    Pennekamp A; Tschirky P; Grossenbacher R
    HNO; 1995 Nov; 43(11):664-8. PubMed ID: 8530314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H
    Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
    Powers RD
    Am J Med; 1993 Mar; 94(3A):155S-158S. PubMed ID: 8452173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Augmentin-induced jaundice with a fatal outcome.
    Hebbard GS; Smith KG; Gibson PR; Bhathal PS
    Med J Aust; 1992 Feb; 156(4):285-6. PubMed ID: 1738330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse hepatic events associated with drug therapy.
    Hewitt J; Hammond L
    Med J Aust; 1996 Sep; 165(6):347, 350. PubMed ID: 8862340
    [No Abstract]   [Full Text] [Related]  

  • 59. [Amoxicillin-clavulanic acid and oral anticoagulants: a possible dangerous association].
    Cauli C; Fenu L; Perra A; Marongiu F
    Ann Ital Med Int; 2004; 19(4):276-9. PubMed ID: 15678708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Amoxicillin and clavulanic acid (Spectramox)--adverse effects on skin].
    Lakartidningen; 1991 Mar; 88(12):1118. PubMed ID: 2016949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.